FJ Labs

Founded in 2015, FJ Labs is a New York-based venture capital firm focusing on stage-agnostic investments in marketplaces and consumer-facing startups. Their investment range varies from $50,000 to $5,000,000, typically at seed or series A stages.

Matias Barbero

Investor

Zineb Belghiti

Analyst

Agapitos Diakogiannis

Investor

Fabrice Grinda

Partner

William Guillouard

Venture Partner

Arne Halleraker

Partner

Christopher Keshian

Investor

Ariel Lebowits

CFO

Mark Lurie

Venture Partner

Jose Marin

Partner

Daniel Simon

Venture Partner

Luke Skertich

Investor

Guimar Vaca Sittic

Venture Partner

Jeff Weinstein

Partner

Andrea Xu

Investor

Past deals in Pets

Laika

Convertible Note in 2023
Laika is an e-commerce platform specializing in a wide range of products and services for pets. The company provides over 4,000 product options, including food, snacks, medications, and accessories. In addition to these offerings, Laika features a services section with more than 17 different services, encompassing healthcare, grooming, and entertainment for pets. With a focus on convenience, Laika delivers all items directly to customers' homes, allowing them to select preferred delivery dates and times, including same-day delivery in major cities. The platform supports various payment methods, ensuring a seamless shopping experience for pet owners seeking to meet their pets' needs.

Napo

Series A in 2022
Napo is a digital-first pet insurance company aiming to transform the market with a comprehensive policy that includes dental care, behavioural support, and preventative resources as standard. Launched in December 2021, it blends AI-driven technology with human care to enable fast, fair claims processing and ongoing support throughout pet ownership, pursuing a six-star customer experience. The company has earned recognition for rapid UK growth and has received awards such as Insurer of the Year at the Modern Claims Awards and Innovation and Rising Star honors at the UK FinTech Awards. Napo envisages a holistic pet care ecosystem offering tools, education, and services to support pets’ health and happiness across life stages, delivered via a digital platform that provides a simple, fast, frictionless experience so pets can live long, healthy lives.

PetsApp

Series A in 2022
PetsApp offers a telemedicine solution for veterinary clinics, facilitating client engagement via text chat, video consultations, and secure payments. It helps clinics monetize previously untapped communication channels, optimize capacity utilization, and generate leads.

Laika

Series B in 2022
Laika is an e-commerce platform specializing in a wide range of products and services for pets. The company provides over 4,000 product options, including food, snacks, medications, and accessories. In addition to these offerings, Laika features a services section with more than 17 different services, encompassing healthcare, grooming, and entertainment for pets. With a focus on convenience, Laika delivers all items directly to customers' homes, allowing them to select preferred delivery dates and times, including same-day delivery in major cities. The platform supports various payment methods, ensuring a seamless shopping experience for pet owners seeking to meet their pets' needs.

Fuzzy

Series C in 2021
Fuzzy, established in 2016 and headquartered in San Francisco, is a pet healthcare startup offering subscription-based services. It aims to make pet care accessible, affordable, and convenient. Through its mobile application, Fuzzy provides 24/7 veterinary consultations via chat and video. Additionally, it offers home delivery of pet essentials such as medications, supplements, and food for dogs and cats. The company's mission is to cater to the personalized needs of pets, allowing owners to manage their pets' health from home. Notable investors include Precursor Ventures, Eniac Ventures, and Matrix Partners.

Embark

Series A in 2019
Embark offers dog DNA testing that ends preventable diseases in dogs. It was founded by top experts in genomics, computational biology, and software design to sell an industry-leading dog DNA test. They use a clinical-grade CLIA-certified SNP chip to provide the most accurate and comprehensive results (200,000+ genetic markers) available on the market. Their data contributes to proprietary genetics research that will help dog owners optimize nutrition, exercise, allergies, and prevent a variety of heritable conditions. Their technological advantage, intellectual capital, and research-focus enable them to push canine health toward our shared vision of preventative veterinary care.

MollyBox

Series B in 2018
Founded in Shanghai, China in 2015 by Yifu Sun and Yi Ju, MollyBox is an e-commerce platform that delivers themed boxes of natural pet foods and toys on a monthly subscription basis.

MollyBox

Series B in 2018
Founded in Shanghai, China in 2015 by Yifu Sun and Yi Ju, MollyBox is an e-commerce platform that delivers themed boxes of natural pet foods and toys on a monthly subscription basis.

Fuzzy

Seed Round in 2017
Fuzzy, established in 2016 and headquartered in San Francisco, is a pet healthcare startup offering subscription-based services. It aims to make pet care accessible, affordable, and convenient. Through its mobile application, Fuzzy provides 24/7 veterinary consultations via chat and video. Additionally, it offers home delivery of pet essentials such as medications, supplements, and food for dogs and cats. The company's mission is to cater to the personalized needs of pets, allowing owners to manage their pets' health from home. Notable investors include Precursor Ventures, Eniac Ventures, and Matrix Partners.

Embark

Seed Round in 2017
Embark offers dog DNA testing that ends preventable diseases in dogs. It was founded by top experts in genomics, computational biology, and software design to sell an industry-leading dog DNA test. They use a clinical-grade CLIA-certified SNP chip to provide the most accurate and comprehensive results (200,000+ genetic markers) available on the market. Their data contributes to proprietary genetics research that will help dog owners optimize nutrition, exercise, allergies, and prevent a variety of heritable conditions. Their technological advantage, intellectual capital, and research-focus enable them to push canine health toward our shared vision of preventative veterinary care.

Embark

Seed Round in 2016
Embark offers dog DNA testing that ends preventable diseases in dogs. It was founded by top experts in genomics, computational biology, and software design to sell an industry-leading dog DNA test. They use a clinical-grade CLIA-certified SNP chip to provide the most accurate and comprehensive results (200,000+ genetic markers) available on the market. Their data contributes to proprietary genetics research that will help dog owners optimize nutrition, exercise, allergies, and prevent a variety of heritable conditions. Their technological advantage, intellectual capital, and research-focus enable them to push canine health toward our shared vision of preventative veterinary care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.